{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:42:58Z","timestamp":1784238178881,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Thyroid dysfunctions are one of the most common abnormalities coexisting in children with Down\u2019s syndrome (DS) and have been reported in up to 54% of cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim of the Study<\/jats:title><jats:p>The purposes of this retrospective study were to investigate the course of subclinical hypothyroidism in children with DS, to evaluate the thyroid function of these subjects in relation to the risk of developing overt thyroid disease and autoimmunity, and to identify clinical and biochemical characteristics of patients prescribed L-T4 therapy in children and adolescents with DS and SH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and Methods<\/jats:title><jats:p>The records of DS patients referred to the Endocrinology Outpatient Clinic between 2010 and 2015 for screening of thyroid function were observed till the end of 2019 June and analyzed retrospectively. The children diagnosed with congenital hypothyroidism, acute lymphoblastic leukemia, and seizures and treated with drugs that may have interfered with thyroid function like lithium, antiepileptic, or iodinated drugs and glucocorticoids were excluded from the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The data of 77 DS patients were collected, evaluated, and analyzed. The study group consisted of 73 patients (32 girls and 41 boys with the mean age at baseline of 3.0 \u00b1 4.5 years). A total of 63\/73 (87%) children were diagnosed with SH. The 16\/63 (25.4%) patients were followed-up without the treatment (group SH-T0), and therapy with levothyroxine (L-T4) was introduced in 47\/63 (74.6%) SH children with a mean dosage of 1.8 \u00b1 1.0 \u03bcg\/kg\/day (group SH-T1). Thyroxine supplementation did not improve growth expressed as \u0394hSDS (0.1 \u00b1 1.3, ranged \u22122.1 to 3.8 in SH-T0 vs. 0.0 \u00b1 0.7, ranged \u22121.7 to 1.4 in SH-T1, <jats:italic>p<\/jats:italic> = 0.96) and \u0394BMI Z-score (0.3 \u00b1 0.9, ranged \u22120.9 to 2.6 in SH-T0 vs. 0.3 \u00b1 1.1, ranged \u22122.1 to 2.9 in SH-T1, <jats:italic>p<\/jats:italic> = 0.65). Positive anti-TPO and anti-TG antibodies were detected in 7\/63 (11.1%) DS cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>SH is the most frequent presentation of thyroid gland dysfunction in DS children. A small percentage of patients develop an overt hypothyroidism, particularly in females with mostly positive titer of antithyroid autoantibodies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.782865","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:22:08Z","timestamp":1641280928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Subclinical Hypothyroidism as the Most Common Thyroid Dysfunction Status in Children With Down\u2019s Syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Kamila","family":"Szeliga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Antosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skrzynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kalina-Faska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Januszek-Trzciakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Gawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s Syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2012.94","article-title":"Twenty-Year Trends in the Prevalence of Down Syndrome and Other Trisomies in Europe: Impact of Maternal Age and Prenatal Screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2002.15.9.1543","article-title":"Thyroid Dysfunction and High Thyroid Stimulating Hormone Levels in Children With Down\u2019s Syndrome","volume":"15","author":"Gruneiro de Papendieck","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2012.08.008","article-title":"Down Syndrome and Thyroid Function","volume":"41","author":"Graber","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","first-page":"56","article-title":"Thyroid Functions in Children With Down\u2019s Syndrome","volume":"91","author":"Unachak","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.049536","article-title":"Longitudinal Study of Thyroid Function in Down\u2019s Syndrome in the First Two Decades","volume":"9","author":"Gibson","year":"2005","journal-title":"Arch Dis Child"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.v142c:3","article-title":"Special Issue: Current Perspectives on Down Syndrome: Selected Medical and Social Issues","author":"Kishnani","year":"2006","journal-title":"Am J Med Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF03349694","article-title":"Natural Course of Subclinical Hypothyroidism in Down\u2019s Syndrome: Prospective Study Results and Therapeutic Considerations","volume":"18","author":"Rubello","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2001.tb01601.x","article-title":"Thyroid Dysfunction in Children With Down\u2019s Syndrome","volume":"90","author":"T\u00fcys\u00fcz","year":"2001","journal-title":"Acta Paediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i1.7120","article-title":"Thyroid Disorders in Subjects With Down Syndrome: An Update","volume":"89","author":"Amr Nermine","year":"2018","journal-title":"Acta Biomed"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.181800","article-title":"Subclinical Hypothyroidism in Childhood","volume":"96","author":"O\u2019Grady","year":"2011","journal-title":"Arch Dis Child"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1988.02150120056040","article-title":"Growth Studies in Infants and Children With Down\u2019s Syndrome and Elevated Levels of Thyrotropin","volume":"142","author":"Sharav","year":"1988","journal-title":"Am J Dis Children"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1991.02160020064018","article-title":"Age-Related Patterns of Thyroid-Stimulating Hor- Mone Response to Thyrotropin-Releasing Hormone Stimulation in Down Syndrome","volume":"145","author":"Sharav","year":"1991","journal-title":"Am J Dis Children"},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2223\/JPED.863","article-title":"Evaluation of the Hypothalamic-Pituitary-Thyroid Axis in Children With Down Syndrome","volume":"78","author":"Oliveira","year":"2002","journal-title":"J Pediatr (Rio J)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000157874","article-title":"Hashimoto\u2019s Thyroiditis in Down\u2019s Syndrome: Clinical Presentation and Evolution","volume":"70","author":"Popova","year":"2008","journal-title":"Horm Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/adc.79.3.242","article-title":"Thyroid Dysfunction in Down\u2019s Syndrome: Relation to Age and Thyroid Autoimmunity","volume":"79","author":"Karlsson","year":"1998","journal-title":"Arch Dis Child"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1574","article-title":"Peculiarities of Presentation and Evolution Over Time of Hashimoto\u2019s Thyroiditis in Children and Adolescents With Down\u2019s Syndrome","volume":"14","author":"Aversa","year":"2015","journal-title":"Hormones"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.046219","article-title":"Cancers and Immune Related Diseases Associated With Down\u2019s Syndrome: A Record Linkage Study","volume":"89","author":"Goldacre","year":"2004","journal-title":"Arch Dis Child"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0484","article-title":"Five-Year Prospective Evaluation of Thyroid Function in Girls With Subclinical Mild Hypothyroidism of Different Etiology","volume":"6","author":"Wasniewska","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0235","article-title":"Underlying Hashimoto\u2019s Thyroiditis Negatively Affects the Evolution of Subclinical Hypothyroidism in Children Irrespective of Other Concomitant Risk Factors","volume":"25","author":"Aversa","year":"2015","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0452","article-title":"In Young Patients With Turner or Down Syndrome, Graves\u2019 Disease Presentation Is Often Preceded by Hashimoto\u2019s Thyroiditis","volume":"24","author":"Aversa","year":"2014","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000382","article-title":"Endocrine Manifestations of Down Syndrome","volume":"25","author":"Whooten","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000362597","article-title":"2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children","volume":"3","author":"Lazarus","year":"2014","journal-title":"Eur Thyroid J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/adc.87.2.97","article-title":"Growth Charts for Down\u2019s Syndrome From Birth to 18 Years of Age","volume":"87","author":"Myrelid","year":"2002","journal-title":"Arch Dis Child"},{"key":"B25","first-page":"1","article-title":"Growth Diagrams, Netherlands. Third Nation-Wide Survey","volume":"63","author":"Roede","year":"1980","journal-title":"Tijdschr Soc Gezondheidsz"},{"key":"B26","volume-title":"Age-Based Pediatric Growth Reference Charts","author":"Shypailo","year":""},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/17477161003615583","article-title":"Defining Obesity Risk Status in the General Childhood Population: Which Cut-Offs Should we Use","volume":"5","author":"de Onis","year":"2010","journal-title":"Int J Pediatr Obes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/17477166.2011.607458","article-title":"Childhood Obesity: Current Definitions and Recommendations for Their Use","volume":"6","author":"Rolland-Cachera","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"B29","volume-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.17-55","article-title":"Evaluation of Uric Acid Levels, Thyroid Function, and Anthropometric Parameters in Japanese Children With Down Syndrome","volume":"61","author":"Niegawa","year":"2017","journal-title":"J Clin Biochem Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fma.2019.06.003","article-title":"Thyroid Disorders in Taiwanese Children With Down Syndrome: The Experience of a Single Medical Center","volume":"119","author":"Ming-Yu","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18544\/EP-01.03.04.0129","article-title":"Thyroid Function In Down Syndrome","volume":"3","author":"Ho\u0142oci\u0144ska-Kwiatkowska","year":"2004","journal-title":"Pediatr Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1986.02140190089034","article-title":"Thyroid Function in Young Children With Down Syndrome","volume":"5","author":"Cutler","year":"1986","journal-title":"Am J Dis Children"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/adc.60.12.1149","article-title":"Thyroid Dysfunction in Down\u2019s Syndrome","volume":"60","author":"Loudon","year":"1985","journal-title":"Arch Dis Child"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1997.tb14808.x","article-title":"The Impact of Thyroid Autoimmunity in Children and Adolescents With Down Syndrome","volume":"86","author":"Ivarsson","year":"1997","journal-title":"Acta P\u00e6diatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/adc.82.1.27","article-title":"School Based Screening for Hypothyroidism in Down\u2019s Syndrome by Dried Blood Spot TSH Measurement","volume":"82","author":"Noble","year":"2000","journal-title":"Arch Dis Child"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.149.9.1990","article-title":"Thyroid Dysfunction in Individuals With Down Syndrome","volume":"149","author":"Friedman","year":"1989","journal-title":"Arch Internal Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0823","article-title":"Prospective Evaluation of Autoimmune and Non-Autoimmune Subclinical Hypothyroidism in Down Syndrome Children","volume":"182","author":"Pepe","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000362450","article-title":"Ten-Year Longitudinal Study of Thyroid Function in Children With Down\u2019s Syndrome","volume":"82","author":"Iughetti","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.26","article-title":"Subclinical Hypothyroidism in the First Years of Life in Patients With Down Syndrome","volume":"73","author":"Claret","year":"2013","journal-title":"Pediatr Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300806","article-title":"Hyperthyrotropinaemia in Untreated Subjects With Down\u2019s Syndrome Aged 6 Months to 64 Years: A Comparative Analysis","volume":"97","author":"Meyerovitch","year":"2012","journal-title":"Arch Dis Child"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000457952","article-title":"Characterization of Thyroid Abnormalities in a Large Cohort of Children With Down Syndrome","volume":"87","author":"Pierce","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The Clinical Significance of Subclinical Thyroid Dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.116","article-title":"Revisiting Early Hypothyroidism Screening in Infants With Down Syndrome","volume":"34","author":"Purdy","year":"2014","journal-title":"J Perinatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1671820","article-title":"Evaluation of Subclinical Hypothyroidism in Children and Adolescents: A Single-Center Study","volume":"16","author":"Such","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1824-7288-39-8","article-title":"Hashimoto\u2019s Thyroiditis in Childhood: Presentation Modes and Evolution Over Time","volume":"39","author":"De Luca","year":"2013","journal-title":"Ital J Pediatr"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302011000800018","article-title":"TSH Neurosecretory Dysfunction (TSH-Nd) in Down Syndrome (DS): Low Risk of Progression to Hashimoto\u2019s Thyroiditis","volume":"8","author":"Faria","year":"2011","journal-title":"Arq Bras Endocrinol e Metabol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5152\/akd.2010.143","article-title":"Evaluation of Congenital Heart Diseases and Thyroid Abnormalities in Children With Down Syndrome","volume":"5","author":"M\u0131h\u00e7\u0131","year":"2010","journal-title":"Anadolu Kardiyol Derg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00109","article-title":"Subclinical Hypothyroidism in Children: When a Replacement Hormonal Treatment Might Be Advisable","volume":"10","author":"Crisafulli","year":"2019","journal-title":"Front Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0833","article-title":"Effects of L-Thyroxine Treatment on Early Markers of Atherosclerotic Disease in Children With Subclinical Hypothyroidism","volume":"175","author":"Cerbone","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B51","first-page":"85","article-title":"L-Thyroxine Therapy and Growth Processes in Children With Down Syndrome","volume":"1","author":"Kowalczyk","year":"2013","journal-title":"Adv Clin Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.23750\/abm.v90i8-S.8503","article-title":"Prevalence of Thyroid Dysfunctions in Infants and Children With Down Syndrome (DS) and the Effect of Thyroxine Treatment on Linear Growth and Weight Gain in Treated Subjects Versus DS Subjects With Normal Thyroid Function: A Controlled Study","volume":"90","author":"Alaaraj","year":"2019","journal-title":"Acta Biomed"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0130","article-title":"The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial","volume":"6","author":"van Trotsenburg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2016.09.019","article-title":"Growing Up With Down Syndrome: Development From 6 Months to 10.7 Years","volume":"59","author":"Marchal","year":"2016","journal-title":"Res Dev Disabil"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1177\/0009922820941247","article-title":"Incidence of Celiac Disease in Down Syndrome: A Longitudinal, Population-Based Birth Cohort Study","volume":"59","author":"Ostermaier","year":"2020","journal-title":"Clin Pediatr"},{"key":"B56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/peds.2011-1605","article-title":"Health Supervision for Children With Down Syndrome","volume":"128","year":"2011","journal-title":"Pediatrics"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.782865\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:22:17Z","timestamp":1641280937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.782865\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":56,"alternative-id":["10.3389\/fendo.2021.782865"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.782865","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"article-number":"782865"}}